Clinical Trial

GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections

Study acronym: ARISE III
Recruiting
View on ClinicalTrials.gov →
Summary
To assess the safety and effectiveness of the ASG device in the treatment of de novo Type A aortic dissections.
Protocol Amendment History 2 changes
notable Trial sites expanded: 18 -> 22 locations 2026-08-12
notable Trial sites expanded: 13 -> 16 locations 2026-04-15
Trial Details
NCT Number NCT06827990
Lead Sponsor W.L.Gore & Associates
Conditions Aortic Dissection
Enrollment 112 participants
Start Date 2025-09-22
Primary Completion 2030-09-01 (estimated)
Study Completion 2031-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-11